Author:
Yanamadala Janakinadh,Borwankar Raunak,Makarov Sergey,Pascual-Leone Alvaro
Publisher
Springer International Publishing
Reference66 articles.
1. Rossi, S., et al.; Safety of TMS Consensus Group. (2009). Safety ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clinical Neurophysiology, 120(12), 2008–2039.
2. Fox, M. D., et al. (2013). Identification of reproducible individualized targets for treatment of depression with TMS based on intrinsic connectivity. NeuroImage, 66, 151–160.
3. DeNoon, D. J. (2008, October). Brain-stimulating device cleared for depression treatment after 1 drug failure. WebMD. [Online]. Available:
http://www.webmd.com/depression/news/20081008/fda-oks-tms-depression-device
4. Brainsway. (2013, Jan.) gets FDA approval for anti-depression device. Reuters. [Online]. Available:
http://www.reuters.com/article/2013/01/09/brainsway-fda-idUSL5E9C99OU20130109
5. Kim, D. R., et al. (2011). An open label pilot study of transcranial magnetic stimulation for pregnant women with major depressive disorder. Journal of Women’s Health, 20(2), 255–261.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献